Title: Harnessing the power of teams to build better models of disease in real time: If not now, then when.

Dr. Stephen Friend is the President of Sage Bionetworks. He was previously Senior Vice President and Franchise Head for Oncology Research at Merck & Co., Inc., where he led Merck’s Basic Cancer Research efforts. He led the Advanced Technologies and Oncology groups to firmly establish molecular profiling activities throughout Merck’s laboratories around the world, as well as to coordinate oncology programs from basic research through phase IIA clinical trials.